Endocrinology and Metabolism Clinics of North America This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Social Determinants of Health Screening in Type 1 Diabetes Management
Type 1 diabetes management is intricately influenced by social determinants of health. Economic status impacts access to vital resources like insulin and diabetes technology. Racism, social injustice, and implicit biases affect equitable delivery of care. Education levels affect understanding of self-care, leading to disparities in glycemic outcomes. Geographic location can limit access to health care facilities. Stressors from discrimination or financial strain can disrupt disease management. Addressing these social factors is crucial for equitable diabetes care, emphasizing the need for comprehensive strategies that go b...
Source: Endocrinology and Metabolism Clinics of North America - October 17, 2023 Category: Endocrinology Authors: Nana-Hawa Yayah Jones, India Cole, Kelsey J. Hart, Sarah Corathers, Shivani Agarwal, Ori Odugbesan, Osagie Ebekozien, Manmohan K. Kamboj, Michael A. Harris, Kathryn L. Fantasia, Mona Mansour Source Type: research

Type 1 Diabetes Screening and Diagnosis
Those with concerning signs or symptoms should be evaluated for type 1 diabetes (T1D). Those with first-degree relatives with T1D or based on the presence of high-risk genes are at increased risk and benefit from screening. Universal screening should be considered in light of new potential therapies to delay disease progression. Although oral glucose tolerance test is the gold standard for T1D staging, there are multiple tools available when oral glucose tolerance test is not feasible. Risk score calculations increase the ability to predict disease progression. Testing should be repeated when symptoms of overt diabetes mel...
Source: Endocrinology and Metabolism Clinics of North America - October 17, 2023 Category: Endocrinology Authors: Patricia Gomez, Janine Sanchez Source Type: research

Optimizing Glycemic Outcomes for Children with Type 1 Diabetes
Changes in physical growth, neurocognitive development, and pubertal maturation are some of the challenges to achieving blood glucose targets in children with type 1 diabetes mellitus. To optimize glycemic outcomes, a comprehensive approach is crucial to address psychosocial needs, expand the use of diabetes technology, and diminish health inequities. (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - October 11, 2023 Category: Endocrinology Authors: Vickie Wu, Lauryn Choleva, Meredith Wilkes Source Type: research

Type 1 Diabetes and Cardiovascular Health
Type 1 diabetes (T1D) is associated with an increased risk of cardiovascular disease (CVD). CVD occurs much earlier in people with T1D than in the general population, and several risk factors have been identified some of which are modifiable. Risk prediction models and imaging tests to detect early signs of CVD have not been extensively validated. Strategies to promote cardiovascular health (CVH) in T1D include identifying risk factors, early treatment to achieve CVH targets, and improving the education of health care providers and people with T1D. (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - October 3, 2023 Category: Endocrinology Authors: Maria Pesantez, Osagie Ebekozien, Francesco Vendrame Source Type: research

The Evolving Landscape of Type 1 Diabetes Management
Type 1 diabetes (T1D) care in the United States has evolved in the last decade.1 The global incidence of T1D is estimated to be 15 per 100,000 people, while prevalence is 5.9 per 10,000.2 By 2040, T1D is projected to impact 13.5 to 17.4 million people.3 (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - September 21, 2023 Category: Endocrinology Authors: Osagie Ebekozien Tags: Preface Source Type: research

Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes
Individuals living with type 1 diabetes (T1D) from medically underserved communities have poorer health outcomes. Efforts to improve outcomes include a focus on team-based care, activation of behavior change, and enhancing self-management skills and practices. Advanced diabetes technologies are part of the standard of care for adults with T1D. However, health care providers often carry implicit biases and may be uncomfortable with recommending technologies to patients who have traditionally been excluded from efficacy trials or have limited real-world exposure to devices. We review the literature on this topic and provide ...
Source: Endocrinology and Metabolism Clinics of North America - August 24, 2023 Category: Endocrinology Authors: Devin W. Steenkamp, Kathryn L. Fantasia, Howard A. Wolpert Source Type: research

Emerging Technologies and Therapeutics for Type 1 Diabetes
Recent years witnessed advancements in diabetes technologies and therapeutics. People with type 1 diabetes have more options to control their blood glucose, prevent hypoglycemia, and spend more time with their loved ones. Newer diabetes technologies and therapeutics improve the quality of life and boost the confidence of people with type 1 diabetes. In parallel to changes in the diabetes technology field, stem cell research has been evolving. Gene editing and production of β cells from stem cells are ongoing. The current focus of cure studies is how to increase the survival of cells produced with stem cells. New adjunctiv...
Source: Endocrinology and Metabolism Clinics of North America - August 18, 2023 Category: Endocrinology Authors: Halis Kaan Akturk, Alexis M. McKee Source Type: research

Disparities in Endocrinology Care
Inequities in medicine have been recognized for a very long time. Disparities have received recent attention in all the major journals and even more so in specialty journals. Much has been written about the pandemic ’s effect and how it highlighted disparities in medical care. This year, it is time to critically examine disparities in endocrinology. At the recently concluded Endocrine Society meeting in Chicago, there was a session devoted to disparities, and a comprehensive article followed. It is therefore time that an issue be devoted to examining health equity in endocrinology. (Source: Endocrinology and Metabolism C...
Source: Endocrinology and Metabolism Clinics of North America - August 14, 2023 Category: Endocrinology Authors: Robert Rapaport Tags: Foreword Source Type: research

Metabolic-Associated Fatty Liver Disease
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - July 25, 2023 Category: Endocrinology Authors: Sherouk Fouda, Joseph M. Pappachan Source Type: research

Copyright
Elsevier (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - July 25, 2023 Category: Endocrinology Source Type: research

Contributors
ROBERT RAPAPORT, MD (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - July 25, 2023 Category: Endocrinology Source Type: research

Contents
Robert Rapaport (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - July 25, 2023 Category: Endocrinology Source Type: research

Forthcoming Issues
Health Equity in Endocrinology (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - July 25, 2023 Category: Endocrinology Source Type: research

Endocrinology and Fatty Liver Disease
The last decade has witnessed a significant increase in the incidence and prevalence of obesity, diabetes, and their metabolic consequences in both the pediatric and the adult populations. Among those complications, there was a tremendous increase in what patients describe as fatty liver disease. Therefore, it is appropriate that an issue be devoted to metabolic-associated fatty liver disease. This issue discusses its pathogenesis and associated conditions, including its occurrence in the “lean” populations. (Source: Endocrinology and Metabolism Clinics of North America)
Source: Endocrinology and Metabolism Clinics of North America - July 25, 2023 Category: Endocrinology Authors: Robert Rapaport Tags: Foreword Source Type: research

Racial and Ethnic Disparities in Metabolic Bone Disease
Racial and ethnic disparities exist in the prevalence and management of osteoporosis, metastatic cancer, and sickle cell disease. Despite being the most common metabolic bone disease, osteoporosis remains underscreened and undertreated among Black women. Skeletal-related events in metastatic cancer include bone pain, pathologic fractures, and spinal cord compression. Disparities in screening for and treating skeletal-related events disproportionately affect Black patients. Metabolic bone disease contributes significantly to morbidity in sickle cell disease; however, clinical guidelines for screening and treatment do not cu...
Source: Endocrinology and Metabolism Clinics of North America - June 25, 2023 Category: Endocrinology Authors: Lauren Y. Maldonado, Linette Bosques, Sara J. Cromer, Sharl S. Azar, Elaine W. Yu, Sherri-Ann M. Burnett-Bowie Source Type: research